Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-29 Sale |
2025-01-30 12:10 pm |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
278 | $29.52 | $8,208 | 55,312 (Direct) |
View |
| 2025-01-22 Sale |
2025-01-23 3:26 pm |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
1,291 | $30.43 | $39,279 | 55,590 (Direct) |
View |
| 2025-01-13 Sale |
2025-01-14 4:15 pm |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
264 | $28.7 | $7,577 | 56,881 (Direct) |
View |
| 2024-12-23 Sale |
2024-12-27 4:06 pm |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
63 | $33.09 | $2,085 | 57,145 (Direct) |
View |
| 2024-01-29 Sale |
2024-01-31 4:23 pm |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
1,250 | $65.22 | $81,524 | 57,208 (Direct) |
View |
| 2024-01-23 Sale |
2024-01-24 4:03 pm |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
7,378 | $63.69 | $469,905 | 58,458 (Direct) |
View |
| 2024-01-22 Sale |
2024-01-23 6:05 pm |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
1,607 | $65 | $104,449 | 65,836 (Direct) |
View |
| 2024-01-17 Sale |
2024-01-18 4:55 pm |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
5,207 | $65.58 | $341,475 | 67,443 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 12:24 pm |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
438 | $66.81 | $29,262 | 101,017 (Direct) |
View |
| 2023-12-26 Sale |
2023-12-28 4:13 pm |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
303 | $59.7 | $18,089 | 53,580 (Direct) |
View |
| 2023-02-23 Sale |
2023-02-27 4:34 pm |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
1,646 | $68.76 | $113,179 | 53,883 (Direct) |
View |
| 2023-01-30 Sale |
2023-01-31 4:51 pm |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
883 | $52.76 | $46,587 | 46,468 (Direct) |
View |
| 2023-01-23 Sale |
2023-01-25 4:14 pm |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
4,479 | $51.58 | $231,027 | 47,718 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-16 Option Award |
2024-01-17 12:24 pm |
N/A 2034-01-15 |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
28,367 | $66.3 | 101,017 (Direct) |
View |
| 2024-01-16 Option Award |
2024-01-17 12:24 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
19,508 | $0 | 101,017 (Direct) |
View |
| 2023-02-21 Tax Withholding |
2023-02-22 06:46 am |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
825 | $58.5 | 69,552 (Direct) |
View |
| 2023-02-21 Option Award |
2023-02-22 06:46 am |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
23,909 | $0 | 69,552 (Direct) |
View |
| 2023-01-27 Tax Withholding |
2023-01-30 4:58 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
367 | $52.77 | 47,351 (Direct) |
View |
| 2023-01-20 Tax Withholding |
2023-01-24 5:15 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
2,033 | $52.05 | 52,197 (Direct) |
View |
| 2023-01-12 Option Award |
2023-01-17 7:35 pm |
N/A 2033-01-11 |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
35,472 | $52.66 | 89,702 (Direct) |
View |
| 2023-01-12 Option Award |
2023-01-17 7:35 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Chief Development Officer |
22,580 | $0 | 89,702 (Direct) |
View |
| 2022-04-25 Other |
2022-12-23 4:15 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Exec VP, Program Team Lead |
1,250 | $0 | 32,900 (Direct) |
View |
| 2022-12-22 Tax Withholding |
2022-12-23 4:15 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Exec VP, Program Team Lead |
89 | $51.68 | 32,900 (Direct) |
View |
| 2022-01-28 Tax Withholding |
2022-02-01 6:09 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Exec VP, Program Team Lead |
434 | $38.59 | 32,989 (Direct) |
View |
| 2022-01-21 Option Award |
2022-01-25 4:50 pm |
N/A 2032-01-20 |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Exec VP, Program Team Lead |
63,002 | $0 | 70,374 (Direct) |
View |
| 2021-12-22 Tax Withholding |
2021-12-23 4:49 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Exec VP, Program Team Lead |
89 | $47.82 | 7,372 (Direct) |
View |
| 2021-03-01 Option Award |
2021-03-03 4:07 pm |
N/A 2031-02-28 |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Exec VP, Program Team Lead |
8,750 | $0 | 14,961 (Direct) |
View |
| 2021-01-28 Option Award |
2021-02-01 4:36 pm |
N/A 2031-01-27 |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Exec VP, Program Team Lead |
35,000 | $0 | 36,211 (Direct) |
View |
| 2020-12-23 Option Award |
2020-12-23 5:41 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey Exec VP, Program Team Lead |
1,211 | $0 | 1,211 (Direct) |
View |
Ownership |
2020-10-06 4:37 pm |
N/A 2030-08-31 |
Apellis Pharmaceuticals Inc. | APLS | Eisele Jeffrey See Remarks |
0 | $0 | 125,000 (Direct) |
View |